While Globus Medical Inc has underperformed by -1.21%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, GMED fell by -9.92%, with highs and lows ranging from $62.88 to $43.38, whereas the simple moving average fell by -0.87% in the last 200 days.
On March 18, 2024, BTIG Research Upgraded Globus Medical Inc (NYSE: GMED) to Buy. A report published by ROTH MKM on October 20, 2023, Initiated its previous ‘Buy’ rating for GMED. Stifel also Upgraded GMED shares as ‘Buy’, setting a target price of $61 on the company’s shares in a report dated September 19, 2023. BofA Securities February 13, 2023d its ‘Buy’ rating to ‘Underperform’ for GMED, as published in its report on February 13, 2023. Wells Fargo’s report from February 10, 2023 suggests a price prediction of $67 for GMED shares, giving the stock a ‘Equal Weight’ rating. Truist also rated the stock as ‘Hold’.
Analysis of Globus Medical Inc (GMED)
Further, the quarter-over-quarter increase in sales is 124.60%, showing a positive trend in the upcoming months.
To gain a thorough understanding of Globus Medical Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of 4.20% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.72, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and GMED is recording an average volume of 1.15M. On a monthly basis, the volatility of the stock is set at 2.65%, whereas on a weekly basis, it is put at 2.29%, with a gain of 2.44% over the past seven days. Furthermore, long-term investors anticipate a median target price of $64.89, showing growth from the present price of $52.47, which can serve as yet another indication of whether GMED is worth investing in or should be passed over.
How Do You Analyze Globus Medical Inc Shares?
A leading company in the Medical Devices sector, Globus Medical Inc (GMED) is based in the USA. When comparing Globus Medical Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 45.05, there is a growth in quarterly earnings of -77.91%.
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 17.25%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 80.08% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
GMED shares are owned by institutional investors to the tune of 80.08% at present.
